From June 26 to 28, 2012, the 12th China World Pharmaceutical Raw Materials Exhibition CPHI China was held in Shanghai New International Expo Center. As the most influential exhibition in the field of pharmaceutical raw materials in Asia, CPHI China holds a significant position in the industry and has international appeal. This exhibition not only serves as a place for exhibitors to contact old customers and meet new customers, but also a platform for exhibitors to recommend new products and understand industry trends.

　　As an EU GMP manufacturer of raw materials, we also participated in this exhibition together. This exhibition is a specially designed booth with a unique design and prominent theme, which has played a great role in promoting the company and its products. Especially in 2010, Irinotecan Hydrochloride passed the Japanese PMDA audit, and in 2011, the company's products Rutin, Triclovir J, and Irinotecan Hydrochloride passed the EU GMP certification. Additionally, the company submitted FDA documents for Irinotecan, Anatrazole, Letrozole, and Docetaxel, attracting the attention of more new and old customers, making great contributions to our company's future development at home and abroad.